Come up with a name for your new list and we'll add to it:
Amplimmune Immunology was acquired by
MedImmune on October 07, 2013.
Amplimmune is a product driven company that is developing immune-based biologics to treat patients in the areas of cancer, autoimmunity, transplantation and infectious diseases. Amplimmune's scientifi…